Pharmeasy-parent’s loss narrows in Q1, revenue up 10%
API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore.
Ebitda turned positive at Rs 39.3 crore.
The company also became debt-free after repaying Rs 1,050 crore.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on economictimes.indiatimes.com — the content belongs to Economic Times - Tech.
